3 completed. 3 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow elsulfavirine: new trials by email Literature Review of elsulfavirine trials Research Report on elsulfavirine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Open Labelled, Randomized Study to Evaluate the Efficacy, Safety and Dose Selection of VM-1500A-LAI Drug in HIV-infected Patients Transferred From Previous Stable Therapy (NNRTI + 2NRTI), Including ELPIDA® VM-1500A-LAI, ELPIDA® - HIV-1-infection | Phase 1 / Phase 2 | Completed | Viriom | 36 | 2021-01-19 | 2022-01-11 |
| Low Dose Dasatinib (50 mg Daily) as First-line Treatment for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Dasatinib - Chronic Myelogenous Leukemia | Phase 2 | Completed | Hikma Pharmaceuticals LLC | 56 | 2018-11-05 | 2023-09-22 |
| Efficacy, Safety and Optimal Dose of VM-1500 in Comparison to Efavirenz Added to Standard-of-care Antiretroviral Therapy VM-1500, Efavirenz, Antiretroviral therapy (ART) - HIV-1-infection | Phase 2 / Phase 3 | Completed | Viriom | 150 | 2014-08-05 | 2018-09-25 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Leukemia, Myeloid, Chronic-Phase (1)
Viriom (2) · Hikma Pharmaceuticals LLC (1)
Russia (2) · Jordan (1) · Lebanon (1) · Saudi Arabia (1) · Tunisia (1)
Anastasia Pokrovskaya, PhD (1) · Irina Y Tyrnova (1)